Corcept Therapeutics Incorporated Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | $0.22 | $0.22 | $0.22 |
Q2 2024 | 1 | $0.23 | $0.23 | $0.23 |
Q3 2024 | 4 | $0.21 | $0.36 | $0.28 |
Q4 2024 | 1 | $0.28 | $0.28 | $0.28 |
Q1 2025 | 2 | $0.32 | $0.32 | $0.32 |
Q2 2025 | 2 | $0.35 | $0.35 | $0.35 |
Q3 2025 | 2 | $0.45 | $0.45 | $0.45 |
Q4 2025 | 2 | $0.56 | $0.56 | $0.56 |
Corcept Therapeutics Incorporated Earnings Date And Information
Corcept Therapeutics Incorporated last posted its earnings results on Monday, July 29th, 2024. The company reported $0.32 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.09. The company had revenue of 163.80 M for the quarter and had revenue of 482.38 M for the year. Corcept Therapeutics Incorporated has generated $1 earnings per share over the last year ($0.94 diluted earnings per share) and currently has a price-to-earnings ratio of 35.96. Corcept Therapeutics Incorporated has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 30th, 2024 based on prior year's report dates.
Corcept Therapeutics Incorporated Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
07/29/2024 | Q2 2024 | $0.23 | $0.34 | 0.11 | $155.14 M | $163.80 M |
05/01/2024 | Q1 2024 | $0.22 | $0.27 | 0.05 | $146.81 M | |
02/15/2024 | Q4 2023 | $0.26 | $0.30 | 0.04 | $135.41 M | |
11/01/2023 | Q3 2023 | $0.22 | $0.31 | 0.09 | $119.71 M | $123.60 M |
08/02/2023 | Q2 2023 | $0.15 | $0.27 | 0.12 | $109.60 M | $117.72 M |
05/03/2023 | Q1 2023 | $0.19 | $0.15 | -0.04 | $105.65 M | |
02/28/2023 | Q4 2022 | $0.23 | $0.15 | -0.08 | $103.06 M | |
11/03/2022 | Q3 2022 | $0.23 | $0.30 | 0.07 | $107.57 M | $101.73 M |
08/03/2022 | Q2 2022 | $0.24 | $101.00 M | $103.39 M | ||
05/05/2022 | Q1 2022 | $0.24 | $0.20 | -0.04 | $93.69 M | |
02/15/2022 | Q4 2021 | $0.22 | $0.28 | 0.06 | $98.82 M | |
11/03/2021 | Q3 2021 | $0.20 | $0.26 | 0.06 | $97.19 M | $96.13 M |
07/29/2021 | Q2 2021 | $0.16 | $0.23 | 0.07 | $86.84 M | $91.59 M |
05/06/2021 | Q1 2021 | $0.21 | $0.20 | -0.01 | $79.44 M | |
02/23/2021 | Q4 2020 | $0.19 | $0.22 | 0.03 | $85.74 M | |
11/03/2020 | Q3 2020 | $0.21 | $0.19 | -0.02 | $90.87 M | $86.33 M |
08/04/2020 | Q2 2020 | $0.22 | $0.25 | 0.03 | $90.13 M | $88.57 M |
05/04/2020 | Q1 2020 | $0.22 | $0.26 | 0.04 | $93.25 M | |
02/24/2020 | Q4 2019 | $0.26 | $87.90 M | |||
11/07/2019 | Q3 2019 | $0.20 | $0.23 | 0.03 | $78.00 M | $81.51 M |
Corcept Therapeutics Incorporated Earnings: Frequently Asked Questions
-
When is Corcept Therapeutics Incorporated's earnings date?
Corcept Therapeutics Incorporated has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 30th, 2024 based off last year's report dates.
-
Did Corcept Therapeutics Incorporated beat their earnings estimates last quarter?
In the previous quarter, Corcept Therapeutics Incorporated (:CORT) reported $0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $0.23 by $0.09.
-
How can I listen to Corcept Therapeutics Incorporated's earnings conference call?
The conference call for Corcept Therapeutics Incorporated's latest earnings report can be listened to online.
-
How can I read Corcept Therapeutics Incorporated's conference call transcript?
The conference call transcript for Corcept Therapeutics Incorporated's latest earnings report can be read online.
-
How much revenue does Corcept Therapeutics Incorporated generate each year?
Corcept Therapeutics Incorporated (:CORT) has a recorded annual revenue of $482.38 M.
-
How much profit does Corcept Therapeutics Incorporated generate each year?
Corcept Therapeutics Incorporated (:CORT) has a recorded net income of $482.38 M. Corcept Therapeutics Incorporated has generated $1.02 earnings per share over the last four quarters.
-
What is Corcept Therapeutics Incorporated's price-to-earnings ratio?
Corcept Therapeutics Incorporated (:CORT) has a price-to-earnings ratio of 35.96 and price/earnings-to-growth ratio is 3.8.